Pharma BD Deal Intelligence

Mylan Laboratories Inc. / King Pharmaceuticals Inc.

2004 · Acquisition/Merger · $4.0B · Terminated

Stock-for-stock; 0.9 Mylan shares per King share; $16.659/King share; deal terminated February 2005

Key facts

• Announced Jul 26, 2004
• Deal value $4.0B
• Deal type Acquisition/Merger

← Browse all deals  ·  How we score deals